Literature DB >> 31990686

IL-17-producing γδ T cells protect against Clostridium difficile infection.

Yee-Shiuan Chen1, Iuan-Bor Chen1, Giang Pham2, Tzu-Yu Shao2, Hansraj Bangar2, Sing Sing Way2, David B Haslam2.   

Abstract

Colitis caused by Clostridium difficile infection is a growing cause of human morbidity and mortality, especially after antibiotic use in health care settings. The natural immunity of newborn infants and protective host immune mediators against C. difficile infection are not fully understood, with data suggesting that inflammation can be either protective or pathogenic. Here, we show an essential role for IL-17A produced by γδ T cells in host defense against C. difficile infection. Fecal extracts from children with C. difficile infection showed increased IL-17A and T cell receptor γ chain expression, and IL-17 production by intestinal γδ T cells was efficiently induced after infection in mice. C. difficile-induced tissue inflammation and mortality were markedly increased in mice deficient in IL-17A or γδ T cells. Neonatal mice, with naturally expanded RORγt+ γδ T cells poised for IL-17 production were resistant to C. difficile infection, whereas elimination of γδ T cells or IL-17A each efficiently overturned neonatal resistance against infection. These results reveal an expanded role for IL-17-producing γδ T cells in neonatal host defense against infection and provide a mechanistic explanation for the clinically observed resistance of infants to C. difficile colitis.

Entities:  

Keywords:  Bacterial infections; Immunology; Infectious disease; T cells

Year:  2020        PMID: 31990686      PMCID: PMC7190913          DOI: 10.1172/JCI127242

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  98 in total

1.  Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.

Authors:  Charlie G Buffie; Irene Jarchum; Michele Equinda; Lauren Lipuma; Asia Gobourne; Agnes Viale; Carles Ubeda; Joao Xavier; Eric G Pamer
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

2.  Interleukin-17-Producing γδ T Cells Originate from SOX13+ Progenitors that Are Independent of γδTCR Signaling.

Authors:  Nicholas A Spidale; Katelyn Sylvia; Kavitha Narayan; Bing Miu; Michela Frascoli; Heather J Melichar; Wu Zhihao; Jan Kisielow; Amy Palin; Thomas Serwold; Paul Love; Michihiro Kobayashi; Momoko Yoshimoto; Nitya Jain; Joonsoo Kang
Journal:  Immunity       Date:  2018-11-06       Impact factor: 31.745

3.  Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.

Authors:  Mizuho Hasegawa; Takashi Yamazaki; Nobuhiko Kamada; Kazuki Tawaratsumida; Yun-Gi Kim; Gabriel Núñez; Naohiro Inohara
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

4.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

Review 5.  The IL-17 Family of Cytokines in Health and Disease.

Authors:  Mandy J McGeachy; Daniel J Cua; Sarah L Gaffen
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

6.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

7.  Heterogeneity of Clostridium difficile isolates from infants.

Authors:  A Collignon; L Ticchi; C Depitre; J Gaudelus; M Delmée; G Corthier
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

8.  γδ T cells exhibit multifunctional and protective memory in intestinal tissues.

Authors:  Brian S Sheridan; Pablo A Romagnoli; Quynh-Mai Pham; Han-Hsuan Fu; Francis Alonzo; Wolf-Dieter Schubert; Nancy E Freitag; Leo Lefrançois
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

9.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Authors:  Bruno Martin; Keiji Hirota; Daniel J Cua; Brigitta Stockinger; Marc Veldhoen
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

10.  Suppression of airway inflammation by a natural acute infection of the intestinal epithelium.

Authors:  D L Gibbons; S F Y Haque; S L Copestake; J W Wells; A Noble; A L Smith; A C Hayday
Journal:  Mucosal Immunol       Date:  2008-12-24       Impact factor: 7.313

View more
  12 in total

1.  Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.

Authors:  Emily S Cribas; Joshua E Denny; Jeffrey R Maslanka; Michael C Abt
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

Review 2.  γδ T cells in tissue physiology and surveillance.

Authors:  Julie C Ribot; Noëlla Lopes; Bruno Silva-Santos
Journal:  Nat Rev Immunol       Date:  2020-10-14       Impact factor: 53.106

3.  High fat diet induced gut dysbiosis alters corneal epithelial injury response in mice.

Authors:  Kai Kang; Qiang Zhou; Lander McGinn; Tara Nguyen; Yuncin Luo; Ali Djalilian; Mark Rosenblatt
Journal:  Ocul Surf       Date:  2021-11-19       Impact factor: 5.033

4.  Long-term use of broad-spectrum antibiotics affects Ly6Chi monocyte recruitment and IL-17A and IL-22 production through the gut microbiota in tumor-bearing mice treated with chemotherapy.

Authors:  Yanhong Wu; Xiaolei Tang; Feng Hu; Tao Zhu; Hui Liu; Yanjing Xiong; Xiaoxuan Zuo; Aiping Xu; Xiufen Zhuang
Journal:  Immunol Res       Date:  2022-09-23       Impact factor: 4.505

5.  High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signature.

Authors:  A-M Globig; A V Hipp; P Otto-Mora; M Heeg; L S Mayer; S Ehl; H Schwacha; M Bewtra; V Tomov; R Thimme; P Hasselblatt; B Bengsch
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

6.  Murine in utero exposure to simulated complex urban air pollution disturbs offspring gut maturation and microbiota during intestinal suckling-to-weaning transition in a sex-dependent manner.

Authors:  Eva Guilloteau; Patrice Coll; Zhuyi Lu; Madjid Djouina; Mathieu Cazaunau; Christophe Waxin; Antonin Bergé; Ségolène Caboche; Aline Gratien; Elie Al Marj; David Hot; Laurent Dubuquoy; David Launay; Cécile Vignal; Sophie Lanone; Mathilde Body-Malapel
Journal:  Part Fibre Toxicol       Date:  2022-06-15       Impact factor: 9.112

Review 7.  T Cell Responses to the Microbiota.

Authors:  Ivaylo I Ivanov; Timur Tuganbaev; Ashwin N Skelly; Kenya Honda
Journal:  Annu Rev Immunol       Date:  2022-02-03       Impact factor: 32.481

Review 8.  Host Immune Responses to Clostridioides difficile: Toxins and Beyond.

Authors:  Britt Nibbering; Dale N Gerding; Ed J Kuijper; Romy D Zwittink; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2021-12-21       Impact factor: 5.640

9.  Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile.

Authors:  Harish Chandra; Krishna Kant Sharma; Olli H Tuovinen; Xingmin Sun; Pratyoosh Shukla
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism.

Authors:  Akhil A Vinithakumari; Piyush Padhi; Belen Hernandez; Susanne Je-Han Lin; Aaron Dunkerson-Kurzhumov; Lucas Showman; Matthew Breitzman; Caroline Stokes; Yousuf Sulaiman; Chandra Tangudu; Deepa A Kuttappan; Muhammed S Muyyarikkandy; Auriel A Willette; Gregory J Phillips; Vellareddy Anantharam; Ann Perera; Brett A Sponseller; Anumantha Kanthasamy; Shankumar Mooyottu
Journal:  Microbiol Spectr       Date:  2022-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.